Comparison of an interferon-gamma release assay and the tuberculin skin test for diagnosis of latent tuberculosis in homeless people in Iran: a cross-sectional study

References

• Hill L, Blumberg E, Sipan C, Schmitz K, West J, Kelley N, et al. Multi-level barriers to LTBI treatment: a research note. J Immigr Minor Health 2010;12:544–50.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Latent tuberculosis infection: a guide for primary health care providers. Available at: http://www.cdc.gov/tb/publications/LTBI/treatment.htm (accessed 28 March 2012).
   Google Scholar
• Styblo K. Recent advances in epidemiological research in tuberculosis. Adv Tuberc Res 1980;20:1–63.
   PubMedGoogle Scholar
• Cohn DL, O’Brien RJ, Geiter LJ, Gordin F, Hershfield E, Horsburgh C. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 2000;49:1–51.
   Google Scholar
• World Health Organization. Global tuberculosis report, 2014. WHO/HTM/TB/2012.6. WHO; 2014.
   Google Scholar
• Taghizadeh Asl R, Mohammad K, Majdzadeh R. Seasonality pattern of tuberculosis in Iran. J Sch Public Health Inst Public Health Res 2005;3:1–9.
   Google Scholar
• World Health Organization. Working together with businesses: guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace. WHO/HTM/TB/2012.3. WHO, 2012.
   Google Scholar
• Lobato MN, Leary LS, Simone PM. Treatment for latent TB in correctional facilities: a challenge for TB elimination. Am J Prev Med 2003;24:249–53.
   PubMedGoogle Scholar
• Hauck FR, Neese BH, Panchal AS, El-Amin W. Identification and management of latent tuberculosis infection. Am Fam Physician 2009;79:879–86.
   PubMedGoogle Scholar
• Kruczak K, Duplaga M, Sanak M, Cmiel A, Mastalerz L, Sladek K, et al. Comparison of IGRA tests and TST in the diagnosis of latent tuberculosis infection and predicting tuberculosis in risk groups in Krakow, Poland. Scand J Infect Dis 2014;46:649–55.
   PubMed Web of Science ®Google Scholar
• Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis. Expert Rev Mol Diagn 2006;6:413–22.
   PubMed Web of Science ®Google Scholar
• Nyamathi A, Christiani A, Nahid P, Gregerson P, Leake B. A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection. Int J Tuberc Lung Dis 2006;10:775–82.
   PubMed Web of Science ®Google Scholar
• Al Jahdali HH, Baharoon S, Abba AA, Memish ZA, Alrajhi AA, AlBarrak A, et al. Saudi guidelines for testing and treatment of latent tuberculosis infection. Ann Saudi Med 2010;30:38–49.
   PubMed Web of Science ®Google Scholar
• Horsburgh C, Rubin E. Latent tuberculosis infection in the United States. N Engl J Med 2011;364:1441–8.
   PubMed Web of Science ®Google Scholar
• Diel R, Loddenkemper R, Meywald-Walter K, Gottschalk R, Nienhaus A. Comparative performance of tuberculin skin test, QuantiFERON-TB-Gold In Tube assay, and T-Spot. TB test in contact investigations for tuberculosis. Chest 2009;135:1010–18.
   PubMedGoogle Scholar
• Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M, et al. The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One 2011;6:e17984.
   Google Scholar
• Stephan C, Wolf T, Goetsch U, Bellinger O, Nisius G, Oremek G, et al. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 2008;22:2471–9.
   PubMedGoogle Scholar
• Vaziri S, Khazaei S, Neishaboori S, Kanani M, Madani S. The degree of agreement of quantiferon TB gold test and tuberculin skin test in nurses. J Gorgan Univ Med Sci 2011;13:37–43.
   Google Scholar
• Ozdemir D, Annakkaya A, Tarhan G, Sencan I, Cesur S, Balbay O, et al. Comparison of the tuberculin skin test and the quantiferon test for latent Mycobacterium tuberculosis infections in health care workers in Turkey. Jpn J Infect Dis 2007;60:102–5.
   PubMedGoogle Scholar
• Vinton P, Mihrshahi S, Johnson P, Jenkin G, Jolley D, Beverley A. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection. Infect Cont Hosp Epidemiol 2009;30:215–21.
   PubMed Web of Science ®Google Scholar
• Lee S, Liu Y, Huang T, Chen Y, Tsai H, Wann S, et al. Comparison of the interferon-γ release assay and the tuberculin skin test for contact investigation of tuberculosis in BCG-vaccinated health care workers. Scand J Infect Dis 2008;40:373–80.
   PubMedGoogle Scholar
• Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, et al. Comparison of an interferon-γ release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care 2007;175:737–42.
   PubMed Web of Science ®Google Scholar
• Hashemi Shahri M, Fallah Ghajary A, Ansari Moghaddam A, Khadem Sameni F, FayyazJahani F, Ahmadnezhad E. To compare the performance of Quanti-FERON with the tuberculin skin test for identifying latent tuberculosis infection. Iran J Epidemiol 2012;7:57–65.
   Google Scholar
• Mazurek G, LoBue P, Daley C, Bernardo J, Lardizabal A, Bishai W, et al. Comparison of a whole-blood interferon γ assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA 2001;286:1740–7.
   PubMed Web of Science ®Google Scholar
• Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metcheck B, Vermon A, et al. Guidelines for using the QuantiFERONTB Gold test for detecting Mycobacterium tuberculosis infection. United States. MMWR Recomm Rep 2005;54: 49–56.
   PubMedGoogle Scholar
• National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians, UK; 2006.
   Google Scholar
• Martini A, Tomao P, Di Renzi S, Vonesch N, Rubino L, Signorini S, et al. [QuantiFERON-TB Gold test in homeless shelter staff: preliminary results.] G Ital Med Lav Ergon 2007;29(3 Suppl):767–9 (in Italian).
   PubMedGoogle Scholar
• Di Renzi S, Tomao P, Martini A, Capanna S, Rubino L, D’Amico W, et al. Screening for tuberculosis among homeless shelter staff. Am J Infect Control 2012;40:459–61.
   PubMedGoogle Scholar
• Garfein RS, Laniado-Laborin R, Rodwell TC, Lozada R, Deiss R, Burgos JL, et al. Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico. Emerg Infect Dis 2010;16:757.
   PubMed Web of Science ®Google Scholar
• Tabuchi T, Takatorige T, Hirayama Y, Nakata N, Harihara S, Shimouchi A, et al. Tuberculosis infection among homeless persons and caregivers in a high-tuberculosis-prevalence area in Japan: a cross-sectional study. BMC Infect Dis 2011;11:22.
   PubMedGoogle Scholar
• Laurenti P, Bruno S, Quaranta G, La Torre G, Cairo A, Nardella P, et al. Tuberculosis in sheltered homeless population of Rome: an integrated model of recruitment for risk management. Scientific World Journal 2012;2012: 396302.
   Google Scholar
• Laurenti P, Quaranta G, Bruno S, La Torre G, Cairo A, Nardella P, et al. Prevalence of cutipositivity in a sample of homeless shelter population in Rome in the course of Latent Tuberculosis Infection surveillance plan. Preliminary results. Ital J Public Health 2010;7:12–19.
   Google Scholar
• Weinfurter P, Blumberg H, Goldbaum G, Royce R, Pang J, Tapia J, et al. Predictors of discordant tuberculin skin test and QuantiFERON-TB Gold In-Tube results in various high-risk groups. Int J Tuberc Lung Dis 2011;15: 1056–61.
   PubMedGoogle Scholar
• Nogueira P, Abrahão R, Galesi V. Tuberculosis and latent tuberculosis in prison inmates. Rev Saude Publ 2012;46: 119–27.
   PubMedGoogle Scholar
• Linas BP, Wong AY, Freedberg KA, Horsburgh CR. Priorities for screening and treatment of latent tuberculosis infection in the United States. Am J Respir Crit Care Med 2011;184:590–601.
   PubMed Web of Science ®Google Scholar
• Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest 2010;137:401–9.
   PubMed Web of Science ®Google Scholar
• Leung CC, Yam WC, Yew WW, Ho PL, Tam CM, Law WS, et al. T-Spot. TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med 2010;182:834–40.
   PubMed Web of Science ®Google Scholar
• Chan-Yeung M, Dai DL, Cheung AH, Chan FH, Kam KM, Tam CM, et al. Tuberculin skin test reaction and body mass index in old age home residents in Hong Kong. J Am Geriatr Soc 2007;55:1592–7.
   PubMedGoogle Scholar
• Aguado JM, Torre-Cisneros J, Fortún J, Benito N, Meije Y, Doblas A, et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009;48:1276–84.
   PubMed Web of Science ®Google Scholar
• Slater M, Parsonnet J, Banaei N. Investigation of false- positive results given by the QuantiFERON-TB Gold In-Tube assay. J Clin Microbiol 2012;50:3105–7.
   PubMed Web of Science ®Google Scholar
• Gray J, Reves R, Johnson S, Belknap R. Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis. Clin Infect Dis 2012;54:e20–e3.
   PubMed Web of Science ®Google Scholar